MedTrace Logo

Cost-utility of VIRTUAL FIBROWALK

NCT05091697 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2021-12-09

No results posted yet for this study

Summary

The main objective of this study is to assess the effectiveness and cost-utility of the VIRTUAL FIBROWALK multicomponent treatment program as coadjuvant of treatment-as- usual (TAU) compared to TAU alone.

Conditions

  • Fibromyoma;Cervix

Interventions

BEHAVIORAL

Multicomponent treatment VIRTUAL FIBROWALK + TAU

To assess the effectiveness and cost-utility of the virtual multicomponent program (Fibrowalk)

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-26
Primary Completion
2021-12-10
Completion
2021-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05091697 on ClinicalTrials.gov